Tenet Healthcare Corporation
THC Healthcare Medical Care Facilities
Tenet Healthcare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $21.3 billion, up 3.07% from fiscal 2024.
- Revenue
- +6.47%
- EPS
- +291.1%
- Free cash flow
- +39.2%
- Total debt
- +0.42%
Quarter to September 2026, against a year earlier
Follow THC
Alert me
Tenet Healthcare Corporation (THC) P/S ratio
As of 5 November 2026, Tenet Healthcare Corporation (THC) trades at a P/S ratio of 1.0×. Over the past ten years it has ranged from 0.1× (March 2020) to 1.1× (August 2026); the current reading is higher than 100% of that period. That is above the Medical Care Facilities industry median of 1.0× and below the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 0.8× | 42.11% |
| FY2024 | 0.6× | 57.42% |
| FY2023 | 0.4× | 37.55% |
| FY2022 | 0.3× | (39.00%) |
| FY2021 | 0.4× | 88.43% |
| FY2020 | 0.2× | 11.70% |
| FY2019 | 0.2× | 122.59% |
| FY2018 | 0.1× | 13.95% |
| FY2017 | 0.1× | 7.56% |
| FY2016 | 0.1× | (51.64%) |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 0.9× | 29.03% |
| Jun 2026 | 0.7× | (6.17%) |
| Mar 2026 | 0.8× | (9.18%) |
| Dec 2025 | 0.8× | (1.81%) |
| 43 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | 0.5× |
| UHS Universal Health Services, Inc. compare | 0.6× |
| DVA DaVita Inc. compare | 0.9× |
| THC Tenet Healthcare Corporation | 1.0× |
| PACS PACS Group, Inc. compare | 1.4× |
| ENSG The Ensign Group, Inc. compare | 1.9× |
| EHC Encompass Health Corporation compare | 2.2× |
| CON Concentra Group Holdings Parent, Inc. compare | 2.3× |
| CHE Chemed Corporation compare | 2.6× |
| Medical Care Facilities industry median | 1.0× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on THC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement